Redcare Pharmacy NV provided earnings guidance for the full year 2023. For the year, the company confirmed the guidance of net sales EUR 1.7 billion to EUR 1.8 billion.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
116.4 EUR | -1.44% | +0.26% | -11.32% |
06-10 | REDCARE PHARMACY : UBS gives a Sell rating | ZD |
06-06 | REDCARE PHARMACY : Berenberg gives a Buy rating | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.32% | 2.58B | |
-38.99% | 13.74B | |
-37.47% | 10.13B | |
-16.27% | 7.82B | |
+4.30% | 5.82B | |
-15.56% | 5.65B | |
-3.36% | 4.6B | |
+67.88% | 4.35B | |
-8.77% | 3.79B | |
-22.93% | 3.02B |
- Stock Market
- Equities
- RDC Stock
- News Redcare Pharmacy NV
- Redcare Pharmacy NV Provides Earnings Guidance for the Full Year 2023